Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
about
A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortalityActive surveillance for prostate cancer: current evidence and contemporary state of practiceHolmium laser enucleation of the prostate: patient selection and perspectivesVariation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary CareFuture-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.The Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas.Re: Long-term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate CancerIntermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer.Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment StrategiesImproving quality through clinical registries in urology.Expectant management for men with early stage prostate cancer.The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study.Active surveillance for low-risk localized prostate cancer: what do men and their partners think?The uptake of active surveillance for the management of prostate cancer: A population-based analysis.Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.Evaluation of a needle disinfectant technique to reduce infection-related hospitalisation after transrectal prostate biopsy.Active Surveillance in Younger Men With Prostate Cancer.On complexity and homogeneity measures in predicting biological aggressiveness of prostate cancer; Implication of the cellular automata model of tumor growth.Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer.Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsMultiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate CancerComparison of Pathological Outcomes for Men with Low Risk Prostate Cancer from Diverse Practice Settings: Similar Results from Immediate Prostatectomy or Initial Surveillance with Delayed Prostatectomy.Who and when should we screen for prostate cancer? Interviews with key opinion leaders.Decision-making processes among men with low-risk prostate cancer: A survey study.Physicians' perspectives on the informational needs of low-risk prostate cancer patients.Variation in the use of active surveillance for low-risk prostate cancer.
P2860
Q26782066-1ED06102-080D-4D8E-ADE4-23E0B2E979CFQ28066534-571E24D1-563C-4A18-B21D-5F7887C6A0B7Q28072328-EB70DEAF-3879-4FB4-82ED-EA083738EF65Q30385364-18577FBE-F86E-4CD7-8A1A-29E9AF26E24CQ30393322-5973B0A9-64EB-4B51-862F-FC922C2D800EQ34677912-9BB4098A-30AB-472D-A4D0-729C2A8B15E9Q35762861-E35AAB1D-9559-4C14-ABED-0445923B4163Q36522791-92406DBF-779B-4457-9175-ACE83BE42E5EQ36568781-DF3331E3-5E44-45AA-BD6A-0D6D7BDBB232Q36787658-8328FA4C-A933-490F-9068-9055644A0B6CQ36892392-3ABAFC84-B8F1-40E5-B7FC-52970C27986BQ36905270-3BBF8F8C-F04B-4753-B9ED-78143C28C47FQ36913517-E5C931CA-BF16-4F1A-8C6D-D1F863354B24Q37008997-F822B5B4-ACC0-4A00-892E-BAC5239C01EFQ37029385-19A82EE1-BF91-4A50-ACF1-8D2E19ABF3D2Q37095655-55282D9B-9CA7-4708-A977-F0593BC3D077Q38371185-B38D410C-E78C-4FC2-9471-834B247D6C2FQ38469754-7BF3F250-F5A7-446E-8C31-6772D89C9AACQ38758510-662EC2A5-9118-40E4-A018-0CB0B1EBAF2FQ38823187-CC5CBFE1-112E-452F-A21F-5469B3CAF1A1Q38905626-D379375F-5151-4DE6-AEC3-5719E5F0EB08Q39051878-824EBDCE-4507-4A65-9727-07B5CFB55EEDQ39229118-C39B1B1D-45F5-4D71-95A4-F3C8FACDF930Q39262504-398EC6F1-D68D-4150-9899-F47642C84C06Q39559217-7A402407-C688-44E2-8A12-921222EF502DQ40098616-E90FFF57-4543-4081-9D18-9EABE591ED91Q40271880-41474337-045E-4BB8-8AB6-B9C4BCE68DD4Q40437169-58D8EAF7-83D4-4442-AB10-8CB11C394591Q40610953-9E45FAE4-5169-4212-9AE3-52C292B90676Q40797430-0056C358-61BA-4D40-BF78-2E55A5503C3CQ40870014-A0A8DB95-D1D0-4036-A183-25DB605EB60BQ41095691-883701A7-277D-4F5A-BB2D-9DFF4D1F35BEQ42265374-914F7836-0B0B-4883-8A42-29D76CDB0013Q42369849-50B707FD-C8C2-40B3-95FF-6C23D83B451CQ42374568-FB526BDD-AB1A-4961-9030-CA8FE8226155Q42707354-57D80D64-3082-4CB1-97F0-646BC103AA1FQ43152601-89D1EBB0-CE8F-45D2-A52C-CC115D34C3D1Q46259067-E6D49FF6-185F-411D-9595-7C997906DE87Q46916722-1D4C81A6-09A3-4082-BEA8-2352A9763D69Q47809867-A975A256-E6C9-480B-9839-8672103239D0
P2860
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Contemporary use of initial ac ...... with low-risk prostate cancer.
@ast
Contemporary use of initial ac ...... with low-risk prostate cancer.
@en
type
label
Contemporary use of initial ac ...... with low-risk prostate cancer.
@ast
Contemporary use of initial ac ...... with low-risk prostate cancer.
@en
prefLabel
Contemporary use of initial ac ...... with low-risk prostate cancer.
@ast
Contemporary use of initial ac ...... with low-risk prostate cancer.
@en
P2093
P1433
P1476
Contemporary use of initial ac ...... with low-risk prostate cancer.
@en
P2093
Brian R Lane
David C Miller
James E Montie
Michigan Urological Surgery Improvement Collaborative
Paul R Womble
Susan M Linsell
P356
10.1016/J.EURURO.2014.08.024
P407
P577
2014-08-24T00:00:00Z